+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hysteroscope Market - Growth, Trends, and Forecasts (2020 - 2025)

  • PDF Icon


  • 112 Pages
  • June 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4896005
A hysteroscope is used to assess the uterus for diagnosing abnormalities like heavy bleeding, severe cramping, frequent miscarriages, or problems related to conceiving. Hysteroscopes are used mainly for two purposes-operative and diagnostics.

According to National Cancer Institute, in 2017, there were an estimated 793,846 women living with uterine cancer in the United States. Increasing incidence uterine cancer, have been the primary driving factor for the growth of this market. Also, growing demand for minimally invasive diagnosis and treatment equipment and technological advancements in the development of new hysteroscope technologies have also helped the market grow.

However, lack of trained professionals and risk of infection due to equipment have been restraining the growth of this market.

Key Market Trends

Rigid Non-Video Hysteroscope is expected to dominate the market

Rigid operative hysteroscopes are the diagnosis and surgery equipment that require assembly. Rigid Hysteroscopes are more durable than flexible hysteroscopes. The use of rigid hysteroscopes has increased recently as they allow both diagnosis and treatment. Rigid hysteroscopes are used is treatment for various uterine abnormalities like removing polyps and fibroids and treating uterine cancer.

According to the National Cancer Institute, approximately 3.1 percent of women will be diagnosed with uterine cancer at some point during their lifetime, based on 2015-2017 data. As number of these dreadful illnesses increase, the demand for equipment for diagnosis and treatment will also increase. This factor is expected to increase the growth of Rigid Non-Video Hysteroscopes.

North America is expected to dominates the market

According to National Cancer Institute, uterine cancer represents 3.6% of all new cancer cases in the United States. Hence as the prevalence and mortality rate of Uterine cancer increase, the demand for equipment for diagnosis and treatment for such illnesses will increase

Moreover, the United States is a developed country and has a well structured healthcare system. As a result the expenditure on research and developmnet for equipment that are minimally invasive and more effective is also high. Hence, owing to these factors, the United Sates is expected to cover a large share of Hysteroscope Market.

Competitive Landscape

Majority of the Hysteroscope are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness, which has helped the market grow.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Incidence of Uterine Diseases and Abnormalities
4.2.2 Growing Demand of Minimally Invasive Treatment
4.2.3 Technological Advancements Leading to Enhanced Applications
4.3 Market Restraints
4.3.1 Risk of Infection from Hysteroscopes
4.3.2 Lack of Trained Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Rigid Non-Video Hysteroscopes
5.1.2 Flexible Non-Video Hysteroscopes
5.2 By Application
5.2.1 Polypectomy
5.2.2 Myomectomy
5.2.3 Endometrial Ablation
5.2.4 Others
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Services
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 CooperSurgical Inc.
6.1.3 Hologic Inc.
6.1.4 Karl Storz SE & Co. KG
6.1.5 MedGyn Products Inc
6.1.6 Medtronic PLC
6.1.7 Olympus Medical Corporation
6.1.8 Richard Wolf GmbH
6.1.9 Stryker Corporation
6.1.10 Xion Medical GmbH

Companies Mentioned

A selection of companies mentioned in this report includes:

  • B. Braun Melsungen AG
  • CooperSurgical Inc.
  • Hologic Inc.
  • Karl Storz SE & Co. KG
  • MedGyn Products Inc
  • Medtronic PLC
  • Olympus Medical Corporation
  • Richard Wolf GmbH
  • Stryker Corporation
  • Xion Medical GmbH